ICD-10-CM Billable Code

C84.41

Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of head, face, and neck

Clinical Classification Guidelines

Medical Intelligence & Overview

Peripheral T-cell lymphoma, not elsewhere classified (ICD-10 code C84.41), is a type of non-Hodgkin lymphoma that originates in T-cells, a type of immune cell. When this lymphoma affects lymph nodes in the head, face, and neck, it can present unique challenges and symptoms. This guide provides an overview of the condition, its causes, symptoms, diagnostic methods, and treatment options, all explained in patient-friendly language.

Causes & Symptoms

Clinical Causes: The exact cause of peripheral T-cell lymphoma remains unknown. Some cases may be associated with a history of immune system problems or infections. Genetic mutations might play a role in the development of lymphoma cells. Exposure to certain chemicals or environmental factors has been speculated, but definitive links are lacking.

Key Symptoms: Swelling or lumps in the lymph nodes of the head, face, or neck Persistent sore throat or difficulty swallowing Unexplained weight loss Fever that persists without explanation Night sweats Fatigue and feeling generally unwell Skin rashes or redness if the lymphoma involves skin tissues near affected lymph nodes

Diagnostic & Treatment

Diagnosis Path: Physical examination of lymph nodes and surrounding areas to check for swelling or irregularities Biopsy of an affected lymph node to analyze tissue for lymphoma cells Imaging studies such as CT scans or PET scans to determine the extent of the disease Blood tests to evaluate overall health and detect abnormal cells Additional laboratory tests or bone marrow biopsy in some cases to assess whether the lymphoma has spread

Treatment Protocols: Chemotherapy: The primary treatment involving powerful drugs to kill cancer cells Radiation therapy: Using high-energy rays to target specific areas affected by lymphoma Targeted therapy: Medications designed to attack specific molecules involved in lymphoma growth Stem cell transplantation: Considering in some cases to rebuild healthy blood cells after treatment Clinical trials: Participation in research studies exploring new treatments or drug combinations

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C84.41 a billable ICD-10 code?
Yes, C84.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C84.41?
Clinical documentation must specify the nature of Peripheral T-cell lymphoma, not elsewhere classified, lymph nodes of head, face, and neck and any associated comorbidities for accurate reporting.

Cite this Clinical Reference